ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Annals of surgical oncology - 29(2022), 13 vom: 07. Okt., Seite 8608-8609 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chia, Daryl K. A. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© Society of Surgical Oncology 2022 |
---|
doi: |
10.1245/s10434-022-12043-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC207992673X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC207992673X | ||
003 | DE-627 | ||
005 | 20230519012351.0 | ||
007 | tu | ||
008 | 230131s2022 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1245/s10434-022-12043-9 |2 doi | |
035 | |a (DE-627)OLC207992673X | ||
035 | |a (DE-He213)s10434-022-12043-9-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Chia, Daryl K. A. |e verfasserin |4 aut | |
245 | 1 | 0 | |a ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Society of Surgical Oncology 2022 | ||
700 | 1 | |a Sundar, Raghav |4 aut | |
700 | 1 | |a Kim, Guowei |4 aut | |
700 | 1 | |a Ang, Jia Jun |4 aut | |
700 | 1 | |a Lum, Jeffrey H. Y. |4 aut | |
700 | 1 | |a Nga, Min En |4 aut | |
700 | 1 | |a Goh, Giap Hean |4 aut | |
700 | 1 | |a Seet, Je Ee |4 aut | |
700 | 1 | |a Chee, Cheng Ean |4 aut | |
700 | 1 | |a Tan, Hon Lyn |4 aut | |
700 | 1 | |a Ho, Jingshan |4 aut | |
700 | 1 | |a Ngoi, Natalie Y. L. |4 aut | |
700 | 1 | |a Lee, Matilda X. W. |4 aut | |
700 | 1 | |a Muthu, Vaishnavi |4 aut | |
700 | 1 | |a Chan, Gloria H. J. |4 aut | |
700 | 1 | |a Pang, Angela S. L. |4 aut | |
700 | 1 | |a Ang, Yvonne L. E. |4 aut | |
700 | 1 | |a Choo, Joan R. E. |4 aut | |
700 | 1 | |a Lim, Joline S. J. |4 aut | |
700 | 1 | |a Teh, Jun Liang |4 aut | |
700 | 1 | |a Lwin, Aung |4 aut | |
700 | 1 | |a Soon, Yuen |4 aut | |
700 | 1 | |a Shabbir, Asim |4 aut | |
700 | 1 | |a So, Jimmy B. Y. |0 (orcid)0000-0002-9772-7905 |4 aut | |
700 | 1 | |a Yong, Wei Peng |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of surgical oncology |d Springer International Publishing, 1994 |g 29(2022), 13 vom: 07. Okt., Seite 8608-8609 |w (DE-627)182355047 |w (DE-600)1200469-8 |w (DE-576)046647635 |x 1068-9265 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2022 |g number:13 |g day:07 |g month:10 |g pages:8608-8609 |
856 | 4 | 1 | |u https://doi.org/10.1245/s10434-022-12043-9 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2018 | ||
951 | |a AR | ||
952 | |d 29 |j 2022 |e 13 |b 07 |c 10 |h 8608-8609 |